Pacific Biosciences Of California (PACB) Retained Earnings (2010 - 2026)

Pacific Biosciences Of California's Retained Earnings history runs 17 years deep, the most recent figure standing at -$147000.0 for Q1 2026.

• On a quarterly basis, Retained Earnings fell 138.58% year-over-year to -$147000.0 in Q1 2026; TTM through Mar 2026 was -$147000.0, a 138.58% decrease from a year earlier, with the FY2025 full-year figure at -$2.7 billion, down 25.43% from the prior year.
• Retained Earnings climbed to -$147000.0 in Q1 2026 per PACB's latest filing, from -$2.7 billion in the prior quarter.
• Across five years, Retained Earnings topped out at $2.6 billion in Q2 2024 and bottomed at -$2.7 billion in Q4 2025.
• The 5-year median for Retained Earnings is -$147000.0 (2026), against an average of -$99.1 million.
• Across the five-year window, Retained Earnings surged 193272.22% in 2022 and slumped 39565.97% in 2023, its largest moves.
• Year by year, Retained Earnings stood at $2.1 billion in 2022, then tumbled by 187.58% to -$1.8 billion in 2023, then dropped by 16.85% to -$2.1 billion in 2024, then slipped by 25.43% to -$2.7 billion in 2025, then jumped by 99.99% to -$147000.0 in 2026.
• Per Business Quant, the three latest PACB Retained Earnings figures stand at -$147000.0 (Q1 2026), -$2.7 billion (Q4 2025), and $415000.0 (Q3 2025).